Kairos Pharma (KAPA) Common Equity (2023 - 2025)
Kairos Pharma's (KAPA) quarterly Common Equity came in at $6.3 million in Q4 2025, up 32.77% YoY from $4.8 million in Q4 2024, and up 5.74% on a QoQ basis from $6.0 million in Q2 2025.
Kairos Pharma (KAPA) Common Equity (2023 - 2025) Analysis & Trends
Kairos Pharma (KAPA) has 3 years of Common Equity data on file, last reported at $6.3 million in Q4 2025.
- Quarterly Common Equity rose 32.77% year-over-year to $6.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.3 million (up 32.77% YoY) and the FY2025 annual result came in at $6.3 million, up 32.77% from the prior year.
- Common Equity improved to $6.3 million in Q4 2025, from $6.0 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $7.1 million in Q1 2025 to a low of -$2.7 million in Q2 2024.
- A 3-year average of $2.1 million and a median of $3.3 million in 2024 frame the typical range for Common Equity.
- The widest YoY moves for Common Equity: up 397.04% in 2025, down 32.77% in 2025.
- Tracing KAPA's Common Equity over 3 years: stood at -$2.1 million in 2023, then soared by 329.84% to $4.8 million in 2024, then surged by 32.77% to $6.3 million in 2025.
- The last three Common Equity figures came in at $6.3 million (Q4 2025), $6.0 million (Q2 2025), and $7.1 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 6.76 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 5.17 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.35 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 757.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.79 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 22.38 Bn |
| 10 | Kairos Pharma | 5.50 Mn | 168,380.07 | - | 6.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.34 Mn |
| Jun 30, 2025 | 6.00 Mn |
| Mar 31, 2025 | 7.13 Mn |
| Dec 31, 2024 | 4.78 Mn |
| Sep 30, 2024 | 3.33 Mn |
| Jun 30, 2024 | -2.65 Mn |
| Mar 31, 2024 | -2.40 Mn |
| Dec 31, 2023 | -2.08 Mn |
| Sep 30, 2023 | -1.87 Mn |